languag f p 105 spanish f articl type bfn f p 106 articl maritza barranco rodriguez trademark f pharmaceut industri text datelin receiv moment u blockad aim make cuban surrend hunger intensifi cuba pharmaceut industri risen cover back nation economi expect high profit result output product right uniqu world 1993 controversi effect cuban vaccin took new height result epidem chile argentina brazil although reserv purchas vaccin threat epidem must taken consider export vaccin meningococc mening interferon anticholestorelom ppg recombin streptokinas cuba secur new market back research raw materi laboratori made cuba label come big surpris transnat firm unlock trade ambit poor countri mani peopl die lack vaccin cuba alreadi produc cuba rest world pharmaceut industri main beneficiari advanc technolog highli industri nation almost monopoli context cuban broke year ago island produc vaccin type b meningococc mening serotyp produc death among infant popul type b hepat also affect million latin american two vaccin alreadi market countri countri area differ meningococc serotyp exist group expert think acquir vaccin although center diseas control prevent atlanta unit state issu posit assess obstacl market vaccin huge market becom strateg field cuban economi nation forum scienc technolog recent held havana cuban presid fidel castro describ war launch unit state cuban pharmaceut product terribl one could imagin far cuban would go took 1980 short cut biotechnolog genet engin open develop countri cuban began produc interferon seri product treat cancer fight infect result human papiloma viru delay aid manifest person hiv viru product market heberbiotec effect demonstr 160 product obtain genet engin includ eight medic come inject cream eye wash although main result deriv genet engin biotechnolog progress also made chemic pharmaceut product anti ulcer qulcer antibiot biolog remedi 1993 main object cuba pharmaceut sector launch commerci struggl face power market 10 largest notabl pharmacolog enterpris sold 170 billion worth product 1992 new formula present island medicin registr offic thu strengthen arsen medicin high intern demand formula streptokinas use dissolv cardiac thrombosi sever other develop human placenta melanin use cure vitiligo complex field biotherapi contribut monoclon antibodi ior t3 first product regist state pharmaceut control offic dr agustin lage director nation molecular immunolog center told prensa latina center current perform clinic test use sever lymphoma treatment anti cholesterol agent known ppg ateromyxol develop aid molecular biolog current ride crest advertis sale wave among tourist come island look sexual formula come call pill ppg conceiv treat high cholesterol level present enjoy wide accept lack unwant side effect patient report gener improv circul process especi sexual function effect weapon cardiovascular diseas introduc local therapeut scene 1991 1993 report issu univers geneva recogn best anticholesterol drug avail produc pharmaceut product nowaday mean plenti scientif research evid fifth cuban pharmaceut scienc congress nation pharmaceut technolog develop workshop intern antibiot workshop held havana 1993 event assess caribbean nation research potenti island scientist prepar begin product antibiot use method ferment support unit nation develop program undp chemic develop produc achiev product cytostat agent call actinomicina accord dr carlo vallin ploust specialist pharmaceut chemistri center use treat sever type cancer new industri find resourc ocean floor studi speci provid toxin found use neurolog scienc product hydroxyapatit complex phosphat calcium produc sea coral use excel element bone implant stomatolog gain strength innov discoveri year close cancer therapi develop shark cartilag multidisciplinari cuban team elabor expand research began unit state 16 week studi carri termin patient septemb 1993 januari 1993 direct dr jose menendez lopez label new option dr lopez menendez name receiv explain new cancer therapi said product regist sold unit state dietari supplement recent report howev indic clinic research similar complet cuba affirm said result may describ spectacular howev seen highli promis encourag enough press therapeut effort specialist explain cuba began import product cuba produc shark cartilag unsurpass qualiti excel shown simpl spectral analysi formula rich astound collect biolog activ substanc anti inflammatori angiogenet inhibit properti scientist point howev shark cartilag mean divin nectar god use entail magic result cuban experi recogn though strongest neoangiogenesi inhibitor test date